# EDGEWELL PERSONAL CARE Co: Form 10-Q for the period ended Dec 31, 2019

- Company: [EDGEWELL PERSONAL CARE Co](/companies/epc.md) (CIK 1096752)
- Form: 10-Q
- Filed: 2020-02-10
- Accepted by EDGAR: Feb 10, 2020, 16:45 ET
- Period: 2019-12-31
- Accession: 0001096752-20-000009
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1096752/000109675220000009/epc-20191231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1096752/000109675220000009/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2019-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2019-10-01 to 2019-12-31 | $454.0m | us-gaap:Revenues |
| Cost of revenue | 3 months, 2019-10-01 to 2019-12-31 | $260.9m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2019-10-01 to 2019-12-31 | $193.1m | us-gaap:GrossProfit |
| Research and development | 3 months, 2019-10-01 to 2019-12-31 | $13.8m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2019-10-01 to 2019-12-31 | $95.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Interest expense | 3 months, 2019-10-01 to 2019-12-31 | $14.3m | us-gaap:InterestExpense |
| Income tax | 3 months, 2019-10-01 to 2019-12-31 | $7.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2019-10-01 to 2019-12-31 | $22.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2019-10-01 to 2019-12-31 | $0.41 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2019-10-01 to 2019-12-31 | $0.41 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2019-10-01 to 2019-12-31 | 54,400,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2019-10-01 to 2019-12-31 | −$46.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2019-10-01 to 2019-12-31 | $7.6m | us-gaap:PaymentsToAcquireProductiveAssets |
| Current assets | at 2019-12-31 | $946.6m | us-gaap:AssetsCurrent |
| Total assets | at 2019-12-31 | $3.30bn | us-gaap:Assets |
| Current liabilities | at 2019-12-31 | $462.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2019-12-31 | $1.96bn | us-gaap:Liabilities |
| Long-term debt | at 2019-12-31 | $1.10bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2019-12-31 | $0 | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2019-12-31 | $1.35bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 32,774 characters.

(in millions, except per share data, unaudited)

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited Condensed Consolidated Financial Statements and the accompanying notes included in this Quarterly Report on Form 10-Q and our Annual Report on Form 10-K filed with the SEC on November 26, 2019 (the “2019 Annual Report”). The following discussion may contain forward-looking statements that reflect our plans, estimates, and beliefs and involve risks, uncertainties, and assumptions. Our actual results could differ materially from those discussed in these forward-looking statements. Factors that could cause or contribute to these differences include those discussed within “Forward-Looking Statements” below and in Item 1A. Risk Factors and “Forward-Looking Statements” included within our 2019 Annual Report.

#### Forward-Looking Statements

This document contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of Edgewell Personal Care Company (“Edgewell”, “we” or “our Company”) or any of our businesses. Forward-looking statements generally can be identified by the use of words or phrases such as “believe,” “expect,” “expectation,” “anticipate,” “may,” “could,” “intend,” “belief,” “estimate,” “plan,” “target,” “predict,” “likely,” “will,” “should,” “forecast,” “outlook,” or other similar words or phrases. These statements are not based on historical facts, but instead reflect our expectations, estimates, or projections concerning future results or events, including, without limitation, the future earnings and performance of our Company or any of our businesses. These statements are not guarantees of performance and are inherently subject to known and unknown risks, uncertainties and assumptions that are difficult to predict and could cause our actual results to differ materially from those indicated by those statements. We cannot assure you that any of our expectations, estimates or projections will be achieved. The forward-looking statements included in this report are only made as of the date of this report, and we disclaim any obligation to publicly update any forward-looking statement to reflect subsequent events or circumstances, except as required by law. You should not place undue reliance on these statements.

In addition, other risks and uncertainties not presently known to us or that we presently consider immaterial could significantly affect the forward-looking statements. All forward-looking statements should be evaluated with the understanding of their inherent uncertainty. Risks and uncertainties include those detailed from time to time in our publicly filed documents, including in Item 1A. Risk Factors of Part I of our 2019 Annual Report.

#### Non-GAAP Financial Measures

While we report financial results in accordance with GAAP, this discussion also includes Non-GAAP measures. These Non-GAAP measures are referred to as “adjusted” or “organic” and exclude items such as restructuring charges, acquisition and integration planning costs, and the disposition of the Pet and Infant Care business, Feminine and Infant Care evaluation costs, legal settlement expenses, and the amortization of intangibles. Reconciliations of Non-GAAP measures are included within this Management’s Discussion and Analysis of Financial Condition and Results of Operations.

This Non-GAAP information is provided as a supplement to, not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP. We use this Non-GAAP information internally to make operating decisions and believe it is helpful to investors because it allows more meaningful period-to-period comparisons of ongoing operating results. Given the various significant events, including the Project Fuel restructuring and acquisition of Harry's, we view the use of Non-GAAP measures that take into account the impact of these unique events as particularly valuable in understanding our underlying operational results and providing insights into future performance. The information can also be used to perform trend analysis and to better identify operating trends that may otherwise be masked or distorted by the types of items that are excluded. This Non-GAAP information is also a component in determining management’s incentive compensation. Finally, we believe this information provides more transparency. The following provides additional detail on our Non-GAAP measures:

- We analyze our net sales and segment profit on an organic basis to better measure the comparability of results between periods. Organic net sales and organic segment profit exclude the impact of changes in foreign currency, acquisitions, and divestitures (including the disposition of the Infant and Pet Care business). This information is provided because these types of fluctuations can distort the underlying change in net sales and segment profit either positively or negatively.
- Adjusted net earnings and adjusted earnings per share are defined as net earnings and diluted earnings per share excluding items such as restructuring charges, acquisition and integration planning costs, the gain or loss on the disposal of a business, business development evaluation costs, legal settlement expenses, and the related tax effects of these items.
- Adjusted effective tax rate is defined as the effective tax rate excluding items such as restructuring charges, acquisition and integration planning costs, the gain or loss on the disposal of a business, business development evaluation costs, legal settlement expenses, and the related tax effects of these items from the income tax provision and earnings before income taxes.
- Free cash flow is defined as net cash from operating activities less net capital expenditures. Free cash flow conversion is defined as free cash flow as a percentage of net earnings adjusted for the net impact of non-cash impairments.

All comparisons are with the same period in the prior year, unless otherwise noted.

#### Industry and Market Data

Unless we indicate otherwise, we base the information concerning our industry contained or incorporated by reference herein on our general knowledge of and expectations concerning the industry. Our market position, market share, and industry market size are based on our estimates using internal data and data from various industry analyses, our internal research and adjustments, and assumptions that we believe to be reasonable. We have not independently verified data from industry analyses and cannot guarantee its accuracy or completeness. In addition, we believe that data regarding the industry, market size and our market position and market share within such industry provide general guidance but are inherently imprecise and have not been verified by any independent source. Further, our estimates and assumptions involve risks and uncertainties and are subject to change based on various factors, including those discussed in the “Risk Factors” section of our 2019 Annual Report. These, and other factors, could cause results to differ materially from those expressed in the estimates and assumptions. You are cautioned not to place undue reliance on this data.

Retail sales for purposes of market size, market position and market share information are based on retail sales in U.S. dollars.

#### Trademarks and Trade Names

We own or have rights to use trademarks and trade names that we use in conjunction with the operation of our business, which appear throughout this Quarterly Report on Form 10-Q. We also may refer to brand names, trademarks, service marks and trade names of other companies and organizations, and these brand names, trademarks, service marks and trade names are the property of their respective owners.

### Significant Events

### Divestiture

On December 17, 2019, the Company completed the sale of its Infant and Pet Care business included in the All Other segment for $122.5 which included consideration for providing services for up to one year under a transition services agreement. For further information on our restructuring projects, refer to Note 2 of Notes to Condensed Consolidated Financial Statements.

### Project Fuel

In February 2018, we announced Project Fuel, an enterprise-wide transformational initiative that is designed to address all aspects of our business and cost structure, simplifying and transforming the organization, structure and key processes that will enable us to achieve our desired future state operations.

In addition to the expected cost savings and improved profitability, Project Fuel is designed to strengthen our challenger culture and reinforce our consumer-centric organizational focus. It is also designed to simplify the organization and streamline ways of working in order to increase competitiveness, speed and agility, and ensure we have the skills, capabilities and investments needed to compete in a rapidly changing marketplace.

In the first quarter of fiscal 2020, Project Fuel related savings were approximately $15, bringing cumulative savings to $152 for Project Fuel to date. Restructuring and related charges and capital expenditures were $8.0 and $4.8, respectively, in the first quarter of fiscal 2020.

We expect Project Fuel will generate $225 to $240 in total annual gross savings by the end of the 2021 fiscal year. It is expected that the savings generated will be used to fuel investments and brand building in strategic growth initiatives, offset anticipated operational headwinds from inflation and other rising input costs, and improve our overall profitability and cash flow.

To implement the restructuring element of Project Fuel, we estimated one-time pre-tax charges to be approximately $130 to $140, with an additional capital investment of $60 to $70 through the end of fiscal year 2021.

For further information on our restructuring projects, refer to Note 3 of Notes to Condensed Consolidated Financial Statements.

### Executive Summary

The following is a summary of key results for the first quarter of fiscal 2020 compared to the first quarter of fiscal 2019. Net earnings and earnings per share (“EPS”) for the periods presented were impacted by restructuring charges, acquisition and integration planning costs, the gain on the disposition of the Infant and Pet Care business, Feminine and Infant Care evaluation costs, legal settlement expenses, and the impact of the Tax Act as described in the table below. The impact of these items on reported net earnings and EPS are provided as a reconciliation of net earnings and EPS to adjusted net earnings and adjusted diluted EPS, both of which are Non-GAAP measures.

### First Quarter of Fiscal 2020

- Net sales in the first quarter of fiscal 2020 were $454.0, down 0.7% compared to the prior year quarter, inclusive of a 0.2% decline from the sale of the Infant and Pet Care business and a 0.5% decline due to currency movements. Excluding the divestiture of Infant and Pet Care business and currency movements, organic net sales were flat compared to the prior year period, as growth in Sun and Skin Care from increased volumes, was offset by declines in Wet Shave.
- Net earnings in the first quarter of fiscal 2020 was $22.4 compared to a loss of $0.4 in the prior year. On an adjusted basis, as illustrated in the following table, net earnings for the first quarter of fiscal 2020 increased 48.0% to $29.9. The improvement was primarily driven by improved gross margin and lower advertising and promotion expense (“A&P”).
- Net earnings per diluted share during the first quarter of fiscal 2020 were $0.41 compared to a loss of $0.01 in the prior year quarter. On an adjusted basis, as illustrated in the following table, net earnings per diluted share during the first quarter of fiscal 2020 was $0.55 compared to $0.37 in the prior year quarter.

|  | Quarter Ended December 31, Net Earnings 2019 | 2018 | Diluted EPS 2019 | 2018 |
| --- | ---: | ---: | ---: | ---: |
| **Net (Loss) Earnings and Diluted EPS — GAAP** | $22.4 | $(0.4) | $0.41 | $(0.01) |
| Restructuring and related costs, net | 8.0 | 18.5 | 0.15 | 0.34 |
| Acquisition and integration planning costs | 6.2 | 0.5 | 0.11 | 0.01 |
| Gain on sale of Infant and Pet Care business | (5.2) | — | (0.10) | — |
| Feminine and Infant Care evaluation costs | 0.3 | — | 0.01 | — |
| Sun Care reformulation costs | — | 0.1 | — | — |
| Investor settlement expense | — | 0.9 | — | 0.02 |
| Income taxes (1) | (1.8) | 0.6 | (0.03) | 0.01 |
| Adjusted Net Earnings and Adjusted Diluted EPS — Non-GAAP | $29.9 | $20.2 | $0.55 | $0.37 |
| Weighted-average shares outstanding — Diluted |  |  | 54.4 | 54.1 |

(1) Includes Income tax expense for adjustments to Net Earnings and Diluted EPS — GAAP for fiscal 2020 and 2019. Additionally, the first quarter of fiscal 2019 was impacted by $4.7 related to the transition tax from the Tax Act.

### Operating Results

The following table presents changes in net sales for the first quarter of fiscal 2020, as compared to the corresponding period in fiscal 2019, and provides a reconciliation of organic net sales to reported amounts.

### Net Sales

| Net Sales - Total Company Quarter Ended December 31, 2019 | Q1 | % Chg |
| --- | ---: | ---: |
| Net sales - prior year | $457.1 |  |
| Organic | — | —% |
| Impact of Infant and Pet Care divestiture | (1.0) | (0.2)% |
| Impact of currency | (2.1) | (0.5)% |
| Net sales - current year | $454.0 | (0.7)% |

30

For the first quarter of fiscal 2020, net sales were $454.0, a 0.7% decrease when compared with the prior year period. Excluding the impact of the Infant and Pet Care divestiture and currency movements, organic net sales were flat versus the prior year period. Organic net sales growth in the Sun and Skin Care and Feminine Care segments was offset by declines in Wet Shave. North America organic net sales grew for the first time since the fourth quarter of fiscal 2016, increasing 60 basis points over the prior year period.

For further discussion regarding net sales, including a summary of reported versus organic changes, see “Segment Results.”

### Gross Profit

Gross profit was $193.1 during the first quarter of fiscal 2020, as compared to $193.5 in the prior year period. Gross margin as a percent of net sales for the first quarter of fiscal 2020 was 42.5%, representing a 20 basis point increase over the prior year gross margin of 42.3%. The improvement in gross margin percentage compared to the prior year quarter is primarily related to lower sourcing and distribution costs as a result of Project Fuel and positive mix, offset partially by increased price investment and trade spend.

### Selling, General and Administrative Expense

SG&A was $95.0 in the first quarter of fiscal 2020, or 20.9% of net sales, as compared to $87.3 in the prior year period, or 19.1% of net sales. Excluding SG&A costs associated with the acquisition and integration planning, Project Fuel, and expenses associated with the divestiture of the Infant and Pet Care business, SG&A as a percent of net sales increased by 50 basis points. The increase in SG&A as a percent of sales was driven by higher personnel costs in the current year quarter including deferred compensation related expenses. These increases were partially offset by savings generated through reduction of overheads as an initiative for Project Fuel.

### Advertising and Sales Promotion Expense

For the first quarter of fiscal 2020, A&P was $41.1, down $10.5 as compared to the prior year period. A&P spending as a percent of net sales was 9.1%, as compared to 11.3% in the prior year period. The decline in A&P was a planned decrease in spending and is related to the Hydro and Intuition f.a.b. campaigns in the prior year period.

### Research and Development Expense

Research and development expense (“R&D”) for the first quarter of fiscal 2020 was $13.8, compared to $12.6 in the prior year period. As a percent of sales, R&D was 3.0% in the first quarter of fiscal 2020 compared to 2.8% in the prior year period. The increase in R&D as a percent of net sales compared to the prior year is primarily driven by incremental investments in resources and capabilities in support of the Company’s focus on innovation and development.

### Interest Expense Associated with Debt

Interest expense associated with debt for the first quarter of fiscal 2020 was $14.3, a decrease from the prior year period of $16.0. The decline in interest expense was the result of lower average outstanding debt primarily related to the $185 term loan due April 2019 (the “Term Loan”) that was repaid in the second quarter of fiscal 2019. Additionally, there were no borrowings under the U.S. revolving credit facility as of December 31, 2019.

### Other (Income) Expense, Net

Other income was $1.6 in the first quarter of fiscal 2020 compared to expense of $1.3 in the prior year period. The increase compared to the prior period relates to favorable foreign currency exchange contract gains and revaluation of nonfunctional currency balance sheet exposures, partially offset by increased pension expense.

### Income Tax Provision

The effective tax rate for the first quarter of fiscal 2020 was 24.4% compared to 105.7% in the prior year period. The effective tax rate includes the unfavorable impact of the disposition of the Infant and Pet Care business and restructuring and other related costs in lower tax rate jurisdictions. The effective tax rate for the prior period includes a $4.7 increase in tax expense related to net charges from the Tax Act. The rate was also unfavorably impacted by $18.5 of restructuring and other related costs in lower tax rate jurisdictions and unfavorable tax adjustments, including the share-based payment guidance. Excluding the tax impact of restructuring charges, acquisition and integration planning costs, the gain on the disposition of the Infant and Pet Care business, Feminine and Infant Care evaluation costs, and legal settlement expenses, the adjusted effective tax rate was 23.2% and 26.6% for the first quarter of fiscal 2019 and fiscal 2018, respectively. The adjusted effective tax rate for fiscal 2020 is expected to be in the range of 20.0% to 22.0%; however, both the effective tax rate and the adjusted effective tax rate are dependent upon the mix of earnings in various tax jurisdictions.

The following table presents a reconciliation of the adjusted effective tax rate, which is a Non-GAAP measure:

|  | Three Months Ended December 31, 2019 Reported | Adjustments (1) | Adjusted (Non-GAAP) | Three Months Ended December 31, 2018 Reported | Adjustments (1) | Adjusted (Non-GAAP) |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Earnings before income taxes | $29.6 | $9.3 | $38.9 | $7.6 | $20.0 | $27.6 |
| Income tax provision | 7.2 | 1.8 | 9.0 | 8.0 | (0.6) | 7.4 |
| Net (loss) earnings | $22.4 | $7.5 | $29.9 | $(0.4) | $20.6 | $20.2 |
| Effective tax rate | 24.4% |  |  | 105.7% |  |  |
| Adjusted effective tax rate |  |  | 23.2% |  |  | 26.6% |

(1) Includes adjustments for the impact of the Tax Act, restructuring charges, acquisition and integration planning costs, the gain on the divestiture of the Infant and Pet Care business, Feminine and Infant Care evaluation costs, and legal settlement expense. See reconciliation of net earnings to adjusted net earnings.

### Segment Results

The following tables present changes in segment net sales and segment profit for the first quarter of fiscal 2020, compared to the corresponding period in fiscal 2019, and provide a reconciliation of organic segment net sales and organic segment profit to reported amounts. For a reconciliation of segment profit to Earnings before income taxes, refer to Note 14 of Notes to Condensed Consolidated Financial Statements.

### Wet Shave

| Net Sales - Wet Shave Quarter Ended December 31, 2019 | Q1 | % Chg |
| --- | ---: | ---: |
| Net sales - prior year | $287.7 |  |
| Organic | (9.4) | (3.3)% |
| Impact of currency | (1.3) | (0.4)% |
| Net sales - current year | $277.0 | (3.7)% |

Wet Shave net sales for the first quarter of fiscal 2020 decreased 3.7%, inclusive of a 0.4% decline due to currency movements. Excluding the impact of currency movements, organic net sales decreased $9.4, or 3.3%, reflecting declines in Men's Systems and Disposables, partly offset by growth in Women's Systems and Shave Preps. By region, North America organic net sales declined 3.0%, driven by lower volumes and unfavorable pricing, while International markets declined 3.5%, largely impacted by last quarter's increased sales volume ahead of a VAT increase in Japan.

| Segment Profit - Wet Shave Quarter Ended December 31, 2019 | Q1 | % Chg |
| --- | ---: | ---: |
| Segment profit - prior year | $55.0 |  |
| Organic | (2.0) | (3.6)% |
| Impact of currency | (0.1) | (0.2)% |
| Segment profit - current year | $52.9 | (3.8)% |

Wet Shave segment profit for the first quarter of fiscal 2020 was $52.9, down $2.1, or 3.8%, inclusive of the impact of currency movements. Excluding the impact of currency movements, organic segment profit decreased $2.0, or 3.6%, as unfavorable price mix in Men's and Women's Systems and lower volumes were partially offset by planned lower advertising and promotional spend.

### Sun and Skin Care

Sun and Skin Care segment net sales and segment profit are affected by the seasonality of sun care products. As a result, segment net sales and segment profit historically have been higher in the second and third quarters of the fiscal year.

| Net Sales - Sun and Skin Care Quarter Ended December 31, 2019 | Q1 | % Chg |
| --- | ---: | ---: |
| Net sales - prior year | $66.7 |  |
| Organic | 9.1 | 13.6% |
| Impact of currency | (0.7) | (1.0)% |
| Net sales - current year | $75.1 | 12.6% |

Sun and Skin Care net sales for the first quarter of fiscal 2020 increased 12.6%, inclusive of a 1.0% decline due to currency movements. Excluding the impact of currency movements, organic net sales increased $9.1, or 13.6%, driven by volume growth in Sun Care, Grooming, and Wipes, as well as favorable price mix. Geographically, organic net sales growth increased in North America and International, with strong performance in Oceania.

| Segment Profit - Sun and Skin Care Quarter Ended December 31, 2019 | Q1 | % Chg |
| --- | ---: | ---: |
| Segment profit - prior year | $(0.6) |  |
| Organic | 0.8 | 133.3% |
| Impact of currency | (0.1) | (16.6)% |
| Segment loss - current year | $0.1 | 116.7% |

Segment profit for the first quarter of fiscal 2020 was $0.1, an improvement of $0.7 or 116.7% compared to the prior year quarter, inclusive of the impact of currency movements. Excluding the impact of currency movements, organic segment profit increased $0.8, or 133.3%, driven by higher gross margin from higher volumes in North America and Latin America and favorable price mix in Asia Pacific. These increases were partially offset by unfavorable cost mix from higher obsolescence charges in North America and increased A&P spend to support Sun Care in North America and Asia Pacific.

### Feminine Care

| Net Sales - Feminine Care Quarter Ended December 31, 2019 | Q1 | % Chg |
| --- | ---: | ---: |
| Net sales - prior year | $74.7 |  |
| Organic | 0.5 | 0.7% |
| Impact of currency | (0.1) | (0.1)% |
| Net sales - current year | $75.1 | 0.6% |

Feminine Care net sales for the first quarter of fiscal 2020 increased $0.4, or 0.6%, inclusive of a 0.1% decline due to the impact of currency movements. Excluding the impact of currency movements, organic net sales increased 0.7%, driven by volume growth in Sport and o.b. tampons and improved price mix in Gentle Glide partially offset by declines in Stayfree pads.

| Segment Profit - Feminine Care Quarter Ended December 31, 2019 | Q1 | %Chg |
| --- | ---: | ---: |
| Segment profit - prior year | $7.5 |  |
| Organic | 5.6 | 74.7% |
| Impact of currency | — | —% |
| Segment profit - current year | $13.1 | 74.7% |

Feminine Care segment profit for the first quarter of fiscal 2020 was $13.1, an increase of $5.6, or 74.7%. The increase in segment profit was driven by favorable materials price and usage, higher volumes, lower freight costs and lower A&P, of which a portion was shifted to trade spend.

### All Other

The Infant and Pet Care divestiture completed in December 2019 effectively disposed of the entirety of operations of the All Other segment. The results below represent segment performance through the sale date.

| Net Sales - All Other Quarter Ended December 31, 2019 | Q1 | %Chg |
| --- | ---: | ---: |
| Net sales - prior year | $28.0 |  |
| Organic | (0.2) | (0.7)% |
| Impact of divestiture | (1.0) | (3.6)% |
| Impact of currency | — | —% |
| Net sales - current year | $26.8 | (4.3)% |

All Other net sales for the first quarter of fiscal 2020 decreased 4.3%, inclusive of a 3.6% decline from the impact of the Infant and Pet Care divestiture. Excluding the impact of the divestiture, organic net sales declined 0.7% compared to the prior year quarter.

| Segment Profit - All Other Quarter Ended December 31, 2019 | Q1 | %Chg |
| --- | ---: | ---: |
| Segment profit - prior year | $1.2 |  |
| Organic | 0.3 | 25.0% |
| Impact of divestiture | 1.6 | 133.3% |
| Impact of currency | — | —% |
| Segment profit - current year | $3.1 | 158.3% |

All Other segment profit for the first quarter of fiscal 2020 was $3.1, an increase of $1.9, or 158.3% compared to the prior year quarter driven by the divestiture of the Infant and Pet Care business.

### General Corporate and Other Expenses

|  | Quarter Ended December 31, 2019 | 2018 |
| --- | ---: | ---: |
| Corporate expenses | $13.3 | $13.7 |
| Restructuring and related costs | 8.0 | 18.5 |
| Acquisition and integration planning costs | 6.2 | 0.5 |
| Gain on sale of Infant and Pet Care business | (5.2) | — |
| Feminine and Infant Care evaluation costs | 0.3 | — |
| Sun Care reformulation | — | 0.1 |
| Legal expense | — | 0.9 |
| General corporate and other expenses | $22.6 | $33.7 |
| % of net sales | 5.0% | 7.4% |

For the first quarter of fiscal 2020, general corporate expenses were $13.3, or 2.9% of net sales, compared to $13.7, or 3.0% of net sales, in the prior year quarter. The decline in corporate expense relates to Project Fuel savings, prior year legal costs that were not recurring, which was partially offset by increased personnel costs.

### Liquidity and Capital Resources

At December 31, 2019, most of our cash balances were located outside the U.S. Given our extensive international operations, a significant portion of our cash is denominated in foreign currencies. We manage our worldwide cash requirements by reviewing available funds among the many subsidiaries through which we conduct business and the cost effectiveness with which those funds can be accessed. We generally repatriate a portion of current year earnings from select non-U.S. subsidiaries only if the economic cost of the repatriation is not considered material.

The counterparties to deposits consist of a number of major financial institutions. We consistently monitor positions with, and credit ratings of, counterparties both internally and by using outside ratings agencies.

Our total borrowings were $1,117.0 at December 31, 2019. Our total borrowings at September 30, 2019 were $1,231.4.

As of December 31, 2019, we did not have any outstanding borrowings under our unsecured revolving credit facility in the U.S. (the “Revolving Facility”). We had $7.4 of outstanding letters of credit. Taking into account outstanding letters of credit at December 31, 2019, $717.6 remains available under the Revolving Facility. At September 30, 2019, we had outstanding borrowings of $117.0 under the Revolving Facility. The Revolving Facility matures in June 2020 and $600.0 of the senior notes mature in May 2021. We expect to refinance both prior to their maturity.

We had outstanding international borrowings, recorded in Notes payable, of $17.0 and $14.4 as of December 31, 2019 and September 30, 2019, respectively.

Historically, we have generated and expect to continue to generate positive cash flows from operations. Our cash flows are affected by the seasonality of our Sun Care products, resulting in higher net sales and increased cash generated in the second and third quarter of each fiscal year. We believe our cash on hand, cash flows from operations and available borrowing under the Revolving Facility will be sufficient to satisfy our future working capital requirements, interest payments, research and development activities, capital expenditures, and other financing requirements for at least the next 12 months.

Short-term financing needs primarily consist of working capital requirements, principal, and interest payments on our long-term debt. Long-term financing needs will depend largely on potential growth opportunities, including acquisition activity and repayment or refinancing of our long-term debt obligations. We may, from time-to-time, seek to repurchase shares of our common stock. Such repurchases, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors. Our long-term liquidity may be influenced by our ability to borrow additional funds, renegotiate existing debt, and raise equity under terms that are favorable to us.

The expected minimum required contribution to our pension plans in fiscal 2020 is $10.4; however, discretionary contributions may also be made. During the first quarter of fiscal 2020 we contributed $1.3 to our pension plans.

As of December 31, 2019, we were in compliance with the provisions and covenants associated with our debt agreements.

### Cash Flows

A summary of our cash flow activities is provided in the following table:

| Net cash (used by) from: | Three Months Ended December 31, 2019 | 2018 |
| --- | ---: | ---: |
| Operating activities | $(46.9) | $(46.4) |
| Investing activities | 89.7 | (2.9) |
| Financing activities | (135.9) | 24.5 |
| Effect of exchange rate changes on cash | 3.3 | (1.7) |
| Net decrease in cash and cash equivalents | $(89.8) | $(26.5) |

#### Operating Activities

Cash flow used by operating activities was $46.9 during the first quarter of fiscal 2020, compared to $46.4 during the same period in the prior year. Due to the seasonality of our Company’s business, primarily in Sun Care, the first fiscal quarter is typically the lowest operating cash flow quarter of the year.

#### Investing Activities

Cash flow from investing activities was $89.7 during the first quarter of fiscal 2020, compared to cash used by investing activities of $2.9 during the same period in the prior year. During the three months ended December 31, 2019, we collected $95.8 of proceeds from the sale of the Infant and Pet Care business. Capital expenditures were $7.6 during the first quarter of fiscal 2020 compared to $9.4 during the same period in the prior year. Additionally, other investing cash inflows totaled $1.5 during the first quarter of fiscal 2020 compared to $6.5 in the prior year quarter.

#### Financing Activities

Net cash used by financing activities was $135.9 during the first quarter of fiscal 2020, compared to net cash from financing activities of $24.5 during the same period in the prior year. During the first quarter of fiscal 2020, we made repayments of $117.0 on the Revolving Facility. Additionally, financing outflows associated with the Accounts Receivable Facility were $14.9 the first quarter of fiscal 2020 compared to financing outflows of $5.1 in the prior year quarter.

### Share Repurchases

During the first quarter of fiscal 2020, we did not repurchase any shares of our common stock. We have 10.0 common shares available for repurchase in the future under the Board’s authorization to repurchase our common shares. Any future share repurchases may be made in the open market, privately negotiated transactions or otherwise, in such amounts and at such times as we deem appropriate based upon prevailing market conditions, business needs and other factors.

### Commitments and Contingencies

#### Contractual Obligations

During the first three months of fiscal 2020, net repayments on our revolving credit facilities were $117.0. As of December 31, 2019, future minimum repayments of debt were: $600.0 in fiscal 2021, and $500.0 in fiscal 2022.

There have been no other material changes in our contractual obligations since the presentation in our 2019 Annual Report.

## Market risk

As filed, 1,189 characters.

The market risk inherent in our financial instruments and positions represents the potential loss arising from adverse changes in currency rates, commodity prices, and interest rates. At times, we enter into contractual arrangements (derivatives) to reduce these exposures. For further information on our foreign currency derivative instruments, refer to Note 13 of Notes to Condensed Consolidated Financial Statements. As of December 31, 2019, there were no open derivative or hedging instruments for future purchases of raw materials or commodities. Our exposure to interest rate risk relates primarily to our variable-rate debt instruments, which currently bear interest based on LIBOR plus margin. As of December 31, 2019, our outstanding variable-rate debt included $17.0 related to our international, variable-rate note payable. Assuming a one-percent increase in the applicable interest rates, annual interest expense on these variable-rate debt instruments would not increase materially.

There have been no material changes in our assessment of market risk sensitivity since our presentation of Quantitative and Qualitative Disclosures About Market Risk in our 2019 Annual Report.

## Controls and procedures

As filed, 1,522 characters.

### Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures designed to ensure that information required to be disclosed in reports filed under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized, and reported within the specified time periods, and that such information is accumulated and communicated to management, including our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), as appropriate, to allow timely decisions regarding required disclosure.

Our management, with the participation of our CEO and CFO, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of December 31, 2019. Based on that evaluation, our CEO and CFO concluded that, as of that date, our disclosure controls and procedures were effective.

### Changes in Internal Control over Financial Reporting

We implemented changes to internal controls due to the adoption of Accounting Standards Update 2016-02 for leases effective October 1, 2019. These changes include implementing a new lease accounting system and processes to evaluate and account for leases under the new accounting standard. Other than described above, there were no changes in our internal control over financial reporting during the quarter ended December 31, 2019 that have materially affected, or are likely to materially affect, our internal control over financial reporting.

Filed Feb 10, 2020.
Source: SEC EDGAR, the filing index for accession 0001096752-20-000009. Last ingested by Listed: Nov 14, 2026, 23:53 ET. No prices; not investment advice.
